This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Morphosys Ag. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Martin Hessling: Innovator in Antibody Formulations
Introduction
Martin Hessling is a notable inventor based in Biberach an der Riß, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations. His work is characterized by a focus on innovative solutions that address critical medical needs.
Latest Patents
Martin Hessling holds a patent for anti-CD19 antibody formulations. This patent describes a pharmaceutical formulation of an anti-CD19 antibody, which is essential for treating certain types of cancers. The formulation aims to enhance the efficacy and safety of the antibody in clinical applications.
Career Highlights
Hessling is associated with Morphosys AG, a leading biotechnology company that specializes in the development of innovative therapies. His role at Morphosys AG has allowed him to contribute to groundbreaking research and development in the field of antibody-based treatments.
Collaborations
Throughout his career, Martin has collaborated with esteemed colleagues such as Patrick Garidel and Andreas Langer. These collaborations have fostered a productive environment for innovation and have led to advancements in therapeutic formulations.
Conclusion
Martin Hessling's work in the development of anti-CD19 antibody formulations exemplifies his commitment to advancing medical science. His contributions continue to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile